Cannabis Experts Say Weed Reform Is A Race Against Time, Is The DEA Delaying Biden's Rescheduling Proposal?
Portfolio Pulse from Nicolás Jose Rodriguez
The potential rescheduling of cannabis by the DEA is a critical issue for the cannabis industry, with a key hearing scheduled for December 2024. Experts discussed the procedural and political challenges that could delay the process, emphasizing that while rescheduling is a positive step, full descheduling is the ultimate goal for effective regulation.
September 13, 2024 | 3:06 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Anthony Coniglio, CEO of NewLake Capital Partners (OTC:NLCP), participated in a webinar discussing the potential rescheduling of cannabis by the DEA. The outcome could impact the cannabis industry significantly, affecting companies like NLCP.
NLCP is involved in the cannabis industry, and the rescheduling could impact its operations. However, the outcome is uncertain due to potential delays and challenges, leading to a neutral short-term impact.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50